Rany Abend1, Caroline Swetlitz1, Lauren K White1,2, Tomer Shechner3, Yair Bar-Haim4, Courtney Filippi1, Katharina Kircanski1, Simone P Haller1, Brenda E Benson1, Gang Chen5, Ellen Leibenluft1, Nathan A Fox6, Daniel S Pine1. 1. Emotion and Development Branch, National Institute of Mental Health, Bethesda, MD, USA. 2. Children's Hospital of Philadelphia, Philadelphia, PA, USA. 3. Psychology Department, University of Haifa, Haifa, Israel. 4. School of Psychological Sciences and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. 5. Scientific and Statistical Computing Core, National Institute of Mental Health, Bethesda, MD, USA. 6. Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD, USA.
Abstract
BACKGROUND: Anxiety symptoms gradually emerge during childhood and adolescence. Individual differences in behavioral inhibition (BI), an early-childhood temperament, may shape developmental paths through which these symptoms arise. Cross-sectional research suggests that level of early-childhood BI moderates associations between later anxiety symptoms and threat-related amygdala-prefrontal cortex (PFC) circuitry function. However, no study has characterized these associations longitudinally. Here, we tested whether level of early-childhood BI predicts distinct evolving associations between amygdala-PFC function and anxiety symptoms across development. METHODS: Eighty-seven children previously assessed for BI level in early childhood provided data at ages 10 and/or 13 years, consisting of assessments of anxiety and an fMRI-based dot-probe task (including threat, happy, and neutral stimuli). Using linear-mixed-effects models, we investigated longitudinal changes in associations between anxiety symptoms and threat-related amygdala-PFC connectivity, as a function of early-childhood BI. RESULTS: In children with a history of high early-childhood BI, anxiety symptoms became, with age, more negatively associated with right amygdala-left dorsolateral-PFC connectivity when attention was to be maintained on threat. In contrast, with age, low-BI children showed an increasingly positive anxiety-connectivity association during the same task condition. Behaviorally, at age 10, anxiety symptoms did not relate to fluctuations in attention bias (attention bias variability, ABV) in either group; by age 13, low-BI children showed a negative anxiety-ABV association, whereas high-BI children showed a positive anxiety-ABV association. CONCLUSIONS: Early-childhood BI levels predict distinct neurodevelopmental pathways to pediatric anxiety symptoms. These pathways involve distinct relations among brain function, behavior, and anxiety symptoms, which may inform diagnosis and treatment.
BACKGROUND:Anxiety symptoms gradually emerge during childhood and adolescence. Individual differences in behavioral inhibition (BI), an early-childhood temperament, may shape developmental paths through which these symptoms arise. Cross-sectional research suggests that level of early-childhood BI moderates associations between later anxiety symptoms and threat-related amygdala-prefrontal cortex (PFC) circuitry function. However, no study has characterized these associations longitudinally. Here, we tested whether level of early-childhood BI predicts distinct evolving associations between amygdala-PFC function and anxiety symptoms across development. METHODS: Eighty-seven children previously assessed for BI level in early childhood provided data at ages 10 and/or 13 years, consisting of assessments of anxiety and an fMRI-based dot-probe task (including threat, happy, and neutral stimuli). Using linear-mixed-effects models, we investigated longitudinal changes in associations between anxiety symptoms and threat-related amygdala-PFC connectivity, as a function of early-childhood BI. RESULTS: In children with a history of high early-childhood BI, anxiety symptoms became, with age, more negatively associated with right amygdala-left dorsolateral-PFC connectivity when attention was to be maintained on threat. In contrast, with age, low-BIchildren showed an increasingly positive anxiety-connectivity association during the same task condition. Behaviorally, at age 10, anxiety symptoms did not relate to fluctuations in attention bias (attention bias variability, ABV) in either group; by age 13, low-BIchildren showed a negative anxiety-ABV association, whereas high-BIchildren showed a positive anxiety-ABV association. CONCLUSIONS: Early-childhood BI levels predict distinct neurodevelopmental pathways to pediatric anxiety symptoms. These pathways involve distinct relations among brain function, behavior, and anxiety symptoms, which may inform diagnosis and treatment.
Authors: Bram Van Bockstaele; Bruno Verschuere; Helen Tibboel; Jan De Houwer; Geert Crombez; Ernst H W Koster Journal: Psychol Bull Date: 2013-11-04 Impact factor: 17.737
Authors: Jennifer C Britton; Yair Bar-Haim; Frederick W Carver; Tom Holroyd; Maxine A Norcross; Allison Detloff; Ellen Leibenluft; Monique Ernst; Daniel S Pine Journal: J Child Psychol Psychiatry Date: 2011-12-03 Impact factor: 8.982
Authors: Andrew A Nicholson; Daniela Rabellino; Maria Densmore; Paul A Frewen; Christian Paret; Rosemarie Kluetsch; Christian Schmahl; Jean Théberge; Richard W J Neufeld; Margaret C McKinnon; Jim Reiss; Rakesh Jetly; Ruth A Lanius Journal: Hum Brain Mapp Date: 2016-09-20 Impact factor: 5.038
Authors: Koraly Pérez-Edgar; Bethany C Reeb-Sutherland; Jennifer Martin McDermott; Lauren K White; Heather A Henderson; Kathryn A Degnan; Amie A Hane; Daniel S Pine; Nathan A Fox Journal: J Abnorm Child Psychol Date: 2011-08
Authors: Tyson V Barker; Bethany Reeb-Sutherland; Kathryn A Degnan; Olga L Walker; Andrea Chronis-Tuscano; Heather A Henderson; Daniel S Pine; Nathan A Fox Journal: Psychophysiology Date: 2015-09-02 Impact factor: 4.016
Authors: Sheila Shanmugan; Daniel H Wolf; Monica E Calkins; Tyler M Moore; Kosha Ruparel; Ryan D Hopson; Simon N Vandekar; David R Roalf; Mark A Elliott; Chad Jackson; Efstathios D Gennatas; Ellen Leibenluft; Daniel S Pine; Russell T Shinohara; Hakon Hakonarson; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite Journal: Am J Psychiatry Date: 2016-01-22 Impact factor: 18.112
Authors: Joel Stoddard; Wan-Ling Tseng; Pilyoung Kim; Gang Chen; Jennifer Yi; Laura Donahue; Melissa A Brotman; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft Journal: JAMA Psychiatry Date: 2017-01-01 Impact factor: 21.596
Authors: Ashley R Smith; Lauren K White; Ellen Leibenluft; Anastasia L McGlade; Adina C Heckelman; Simone P Haller; George A Buzzell; Nathan A Fox; Daniel S Pine Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-05-23 Impact factor: 8.829
Authors: Simone P Haller; Camille Archer; Annie Jeong; Allison Jaffe; Emily L Jones; Anita Harrewijn; Reut Naim; Julia O Linke; Joel Stoddard; Melissa A Brotman Journal: Child Psychiatry Hum Dev Date: 2022-07-06
Authors: Courtney A Filippi; Sanjana Ravi; Maya Bracy; Anderson Winkler; Chad M Sylvester; Daniel S Pine; Nathan A Fox Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-12-29 Impact factor: 13.113
Authors: Frances L Doyle; Antonio Mendoza Diaz; Valsamma Eapen; Paul J Frick; Eva R Kimonis; David J Hawes; Caroline Moul; Jenny L Richmond; Divya Mehta; Sinia Sareen; Bronte G Morgan; Mark R Dadds Journal: Front Psychiatry Date: 2020-06-19 Impact factor: 4.157
Authors: Stefanie L Sequeira; Dana K Rosen; Jennifer S Silk; Emily Hutchinson; Kristy Benoit Allen; Neil P Jones; Rebecca B Price; Cecile D Ladouceur Journal: Dev Cogn Neurosci Date: 2021-05-05 Impact factor: 6.464
Authors: Rany Abend; Sonia G Ruiz; Mira A Bajaj; Anita Harrewijn; Julia O Linke; Lauren Y Atlas; Anderson M Winkler; Daniel S Pine Journal: Neurobiol Stress Date: 2022-01-04